Reversible posterior encephalopathy syndrome due to intravenous immunoglobulin in a child with Guillain-Barré syndrome

Journal of Pediatric Neurosciences

Volumn 6, Issue 2, 2011, Pages 138-140

  Incecik, Faruk ^a   Hergüner, M Ozlem ^a   Altunbasak, Sakir ^a   Yildizdas, Dincer ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Children; intravenous immunoglobulin; reversible posterior leukoencephalopathy syndrome

Indexed keywords

IMMUNOGLOBULIN;

AGITATION; ARTICLE; CASE REPORT; CHILD; CONSCIOUSNESS; ELECTROMYOGRAPHY; GIANT AXONAL NEUROPATHY; GUILLAIN BARRE SYNDROME; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MALE; MUSCLE HYPOTONIA; MUSCLE STRENGTH; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRESCHOOL CHILD; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION;

EID: 84857861950     PISSN: 18171745     EISSN: 19983948     Source Type: Journal    
DOI: 10.4103/1817-1745.92841     Document Type: Article

References (10)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Van Diest D, Van Goethem JW, Vercruyssen A, Jadoul C, Jadoul C, Cras P, et al. Posterior reversible encephalopathy and Guillain-Barré syndrome in a single patient: Coincidence or causative relation? Clin Neurol Neurosurg 2007;109:58-62.
3. Lamy C, Oppenheim C, Meder JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004;14:89-96.
4. Byrne NP, Henry JC, Herrmann DN, Abdelhalim AN, Shrier DA, Francis CW, et al. Neuropathologic findings in Guillain-Barré patient with stroke after IVIg therapy. Neurology 2002;59:458-61.
5. Mathy I, Gille M, Van Raemdonck F, Delbecq J, Depré A, et al. Neurological complications of intravenous immunoglobulin (IVIg) therapy: An illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg 1998;98:347-51.
6. Voltz R, Rosen FV, Yousry T, Beck J, Hohlfeld R, et al. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin. Neurology 1996;46:250-1.
7. Doss-Esper CE, Singhal AB, Smith MS, Henderson GV. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in Guillain-Barré syndrome. J Neuroimaging 2005;15:188-92.
8. Koichihara R, Hamano S, Yamashita S, Tanaka M. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome. Pediatr Neurol 2008;39:123-5.
9. Takano T, Ohno M, Takeuchi Y, Mandai R, Yoshida S, et al. Cytotoxic edema and interleukin-6 in hypertensive encephalopathy. Pediatr Neurol 2002; 26: 71-73.
10. Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp Neurol 2004;190:446-55.